Deal Values in Pharmaceutical & Healthcare Industry Increased in Q4 2015

The pharmaceutical and healthcare industry reported an increase in deal value in Q4 2015 with USD237.7 billion compared to USD201.3 billion in Q4 2014. However, the number of deals decreased in Q4 2015 with 1,013, as compared to 1,143 in Q4 2014. On a quarter-on-quarter basis, the number of deals decreased and deal values increased in Q4 2015, when compared to 1,053 deals worth USD145.7 billion in Q3 2015. Licensing agreements recorded an increase in upfront payments and milestone payments in Q4 2015. A total of USD867.6m and USD10.4 billion were reported as upfront and milestone payments in Q4 2015, compared to USD729.3m and USD6.5 billion, respectively in Q4 2014.

GlobalData’s Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2015 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on partnerships, licensing agreements, M&As, equity/debt offerings, private equity and venture financing transactions registered in the pharmaceutical and healthcare industry in Q4 2015.

Published: Feb’16 – Single user price: $1,500

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s